|
BSX
|
Healthcare |
Argus |
Downgrade
|
Buy
→
Hold
|
—
|
$68.4B
|
$46.00
|
-0.3%
|
+1.6%
|
+3.6%
|
+1.4%
|
-2.8%
|
+3.3%
|
|
RBLX
|
Technology |
BTIG Research |
Downgrade
|
Neutral
→
Sell
|
$30
|
$34.8B
|
$48.67
|
-20.1%
|
-26.9%
|
+3.0%
|
+0.9%
|
-2.2%
|
-0.4%
|
|
RBLX
|
Technology |
The Benchmark Company |
Downgrade
|
Hold
→
Sell
|
$33
|
$34.8B
|
$48.67
|
-20.1%
|
-26.9%
|
+3.0%
|
+0.9%
|
-2.2%
|
-0.4%
|
|
RBLX
|
Technology |
Wedbush |
Downgrade
|
Outperform
→
Neutral
|
$40
|
$34.8B
|
$48.67
|
-20.1%
|
-26.9%
|
+3.0%
|
+0.9%
|
-2.2%
|
-0.4%
|
|
RBLX
|
Technology |
BMO Capital Markets |
Downgrade
|
Outperform
→
Market Perform
|
$45
|
$34.8B
|
$48.67
|
-20.1%
|
-26.9%
|
+3.0%
|
+0.9%
|
-2.2%
|
-0.4%
|
|
RBLX
|
Technology |
Deutsche Bank |
Downgrade
|
Buy
→
Hold
|
$38
|
$34.8B
|
$48.67
|
-20.1%
|
-26.9%
|
+3.0%
|
+0.9%
|
-2.2%
|
-0.4%
|
|
EIX
|
Utilities |
Barclays |
Downgrade
|
Overweight
→
Equal Weight
|
$75
|
$30.3B
|
$78.73
|
-3.5%
|
-6.8%
|
-2.6%
|
-1.1%
|
-3.4%
|
-1.6%
|
|
GDDY
|
Technology |
William Blair |
Downgrade
|
Outperform
→
Mkt Perform
|
—
|
$13.2B
|
$99.33
|
-22.7%
|
-16.7%
|
+6.9%
|
+0.7%
|
+3.0%
|
-1.5%
|
|
GDDY
|
Technology |
Raymond James |
Downgrade
|
Strong Buy
→
Outperform
|
$100
|
$13.2B
|
$99.33
|
-22.7%
|
-16.7%
|
+6.9%
|
+0.7%
|
+3.0%
|
-1.5%
|
|
RTO
|
Industrials |
BNP Paribas Exane |
Downgrade
|
Outperform
→
Neutral
|
$27
|
$12.2B
|
$24.25
|
-2.6%
|
-3.7%
|
+2.1%
|
+5.1%
|
-1.2%
|
-1.2%
|
|
HXL
|
Industrials |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$7.8B
|
$102.91
|
-0.2%
|
+0.0%
|
-0.7%
|
+1.8%
|
+0.2%
|
-1.3%
|
|
GPI
|
Consumer Cyclical |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
$320
|
$3.4B
|
$296.71
|
-0.9%
|
-3.4%
|
+1.9%
|
-2.1%
|
-2.9%
|
-2.4%
|
|
BXMT
|
Real Estate |
Keefe Bruyette |
Downgrade
|
Outperform
→
Mkt Perform
|
$16
|
$2.5B
|
$14.97
|
-3.2%
|
-2.9%
|
+0.2%
|
-1.0%
|
-3.3%
|
-0.7%
|
|
UPBD
|
Technology |
BTIG Research |
Downgrade
|
Buy
→
Neutral
|
—
|
$1.2B
|
$20.12
|
-0.4%
|
-3.6%
|
+4.7%
|
+1.1%
|
-2.0%
|
-3.0%
|
|
MCS
|
Communication Services |
B. Riley Securities |
Downgrade
|
Buy
→
Neutral
|
$29
|
$918M
|
$29.69
|
-2.2%
|
-2.0%
|
+5.5%
|
+1.4%
|
-1.1%
|
-0.5%
|
|
CCB
|
Financial Services |
Raymond James |
Downgrade
|
Strong Buy
→
Outperform
|
$50
|
$609M
|
$39.91
|
-0.5%
|
+2.7%
|
+4.0%
|
+3.3%
|
+0.2%
|
-0.5%
|
|
KPTI
|
Healthcare |
Robert W. Baird |
Downgrade
|
Outperform
→
Neutral
|
$3
|
$159M
|
$7.01
|
-68.8%
|
-72.6%
|
+2.6%
|
-0.5%
|
-2.6%
|
+2.1%
|
|
KPTI
|
Healthcare |
H.C. Wainwright |
Downgrade
|
Buy
→
Neutral
|
$3
|
$159M
|
$7.01
|
-68.8%
|
-72.6%
|
+2.6%
|
-0.5%
|
-2.6%
|
+2.1%
|